Fortress Biotech Earning Date (FBIOP)

USA |NASDAQ |USD

FBIOP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-0.26 $-0.07
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $17.84M $9.45M

Fortress Biotech's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

FBIOP Earnings Date & History Chart

FBIOP Earnings Date & Revenue History

FBIOP Earnings History

|
Show More
Show More

FBIOP Revenue History

|
Show More
Show More

Fortress Biotech Next Earnings Date & Report

FBIOP Sep 2021 (FQ) Earnings Date & Report Preview

FBIOP's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Fortress Biotech Previous Earnings Dates & Reports

FBIOP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Fortress Biotech's previous earnings date was Sep 30, 2021 for its fiscal quarter ended Jun 30, 2021.

FBIOP's earnings per share (EPS) was $-0.26.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 484.67%, and lower than the same period a year before (Jun 2020) by 25.06%.

Revenues were $17.84M, up by 53.99% from the previous quarter , and up by 88.68% from the same period last year.

The company reported a net income of $-3.54M.

Free cash flow for the quarter was $-39.30M , compared to $-22.15M last quarter and $-16.73M a year before.

FBIOP ended the quarter with $86.50M in total debt, a decrease of -0.97% compared to the previous quarter, and an increase of 0.60% compared to the same quarter a year before.

FBIOP Previous Earnings Date & Report Recap: Dec 2021 (FY)

Revenues were $63.13M, up by 41.78% from previous year's revenue.

The company reported a net income of $-64.70M.

Fortress Biotech reported a free cash flow of $-121.11M for its fiscal year, compared to $-90.85M a year ago.

The company ended the fiscal year with $109.78M in total debt, an increase of 86.61% compared to the previous year.